{
  "meta": {
    "title": "18_Obesity",
    "url": "https://brainandscalpel.vercel.app/18-obesity-1349d3da.html",
    "scrapedAt": "2025-11-30T12:28:27.499Z"
  },
  "questions": [
    {
      "text": "The hormone leptin is derived from which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Arcuate nucleus"
        },
        {
          "id": 2,
          "text": "Adipocytes"
        },
        {
          "id": 3,
          "text": "Chief cells"
        },
        {
          "id": 4,
          "text": "Paneth cells"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Leptin</strong> is an <strong>adipocyte</strong>-derived hormone.</p>\n<p>It acts through brain circuits (predominantly in the hypothalamus) to influence appetite, energy expenditure, and neuroendocrine function.&nbsp;High leptin levels <strong>reduce appetite&nbsp;</strong>and <strong>increase energy expenditure.</strong></p>\n<p>The arcuate nucleus in the hypothalamus plays an important role in the regulation of appetite.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7024",
      "difficulty": "easy"
    },
    {
      "text": "A 25-year-old woman has been fasting all day as part of a new diet. Which of the following is a gut peptide that will be increased in this woman?",
      "choices": [
        {
          "id": 1,
          "text": "Peptide YY"
        },
        {
          "id": 2,
          "text": "Ghrelin"
        },
        {
          "id": 3,
          "text": "Cholecystokinin"
        },
        {
          "id": 4,
          "text": "Orexin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the fasting state, high levels of&nbsp;<strong>ghrelin </strong>are seen. It is a&nbsp;<strong>gut-peptide</strong>&nbsp;produced in the stomach and stimulates<strong> hunger </strong>and<strong> appetite.</strong></p><hr><h3>Related Pearl: Neurotransmitters and Hormones that influence Feeding and Satiety Centers in the Hypothalamus</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Increased Appetite (Orexigenic)</strong></p>\n</td>\n<td>\n<p><strong>Decreased Appetite (Anorexigenic)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Neuropeptide Y</strong></p>\n<p>Agouti-related protein (AGRP)</p>\n<p>Melanin-concentrating hormone (MCH)</p>\n<p><strong>Orexins A and B</strong></p>\n<p>Endorphins</p>\n<p>Galanin</p>\n<p>Amino acids (glutamate and &gamma; aminobutyric acid)</p>\n<p>Cortisol</p>\n<p><strong>Ghrelin</strong></p>\n<p>Growth hormone-releasing hormone (GHRH)</p>\n<p>Endocannabinoids</p>\n</td>\n<td>\n<p><strong>Melanocyte-stimulating hormone</strong> (MSH)</p>\n<p><strong>Leptin</strong></p>\n<p>Serotonin</p>\n<p>Norepinephrine</p>\n<p><strong>Corticotropin-releasing hormone (CRH)</strong></p>\n<p><strong>Insulin</strong></p>\n<p><strong>Cholecystokinin (CCK)</strong></p>\n<p>Glucagon-like peptide</p>\n<p><strong>Cocaine-and amphetamine-regulated transcript (CART)</strong></p>\n<p>Bombesin</p>\n<p>Peptide YY</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7026",
      "difficulty": "medium"
    },
    {
      "text": "A 16-year-old boy ate two pieces of cake, a sandwich, and two scoops of ice cream at his friend's birthday party an hour ago. Levels of which of the following are likely to be high in this boy?",
      "choices": [
        {
          "id": 1,
          "text": "Neuropeptide Y(NPY)"
        },
        {
          "id": 2,
          "text": "Melanin-concentrating hormone(MCH)"
        },
        {
          "id": 3,
          "text": "Œ±- Melanocyte-stimulating hormone(Œ±-MSH)"
        },
        {
          "id": 4,
          "text": "Agouti-related peptide (AgRP)"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This boy is likely to have high levels of &alpha;-Melanocyte-stimulating hormone (<strong>&alpha;-MSH</strong>). It is a hypothalamic peptide that<strong>&nbsp;decreases appetite&nbsp;</strong>and hence would be <strong>increased</strong> in the <strong>fed state</strong>.</p><hr><h3>Related Pearl: Neurotransmitters and Hormones that influence Feeding and Satiety Centers in the Hypothalamus</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Increased Appetite (Orexigenic)</strong></p>\n</td>\n<td>\n<p><strong>Decreased Appetite (Anorexigenic)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Neuropeptide Y</strong></p>\n<p>Agouti-related protein (AGRP)</p>\n<p>Melanin-concentrating hormone (MCH)</p>\n<p><strong>Orexins A and B</strong></p>\n<p>Endorphins</p>\n<p>Galanin</p>\n<p>Amino acids (glutamate and &gamma; aminobutyric acid)</p>\n<p>Cortisol</p>\n<p><strong>Ghrelin</strong></p>\n<p>Growth hormone-releasing hormone (GHRH)</p>\n<p>Endocannabinoids</p>\n</td>\n<td>\n<p><strong>Melanocyte-stimulating hormone</strong> (MSH)</p>\n<p><strong>Leptin</strong></p>\n<p>Serotonin</p>\n<p>Norepinephrine</p>\n<p><strong>Corticotropin-releasing hormone (CRH)</strong></p>\n<p><strong>Insulin</strong></p>\n<p><strong>Cholecystokinin (CCK)</strong></p>\n<p>Glucagon-like peptide</p>\n<p><strong>Cocaine-and amphetamine-regulated transcript (CART)</strong></p>\n<p>Bombesin</p>\n<p>Peptide YY</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7029",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a key transcription factor involved in the differentiation of mesenchymal preadipocytes to adipose cells?",
      "choices": [
        {
          "id": 1,
          "text": "RARŒ≥"
        },
        {
          "id": 2,
          "text": "Rev-erbAŒ≤"
        },
        {
          "id": 3,
          "text": "RXRŒ±"
        },
        {
          "id": 4,
          "text": "PPARŒ≥"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>One of the key transcription factors involved in the differentiation of mesenchymal <strong>preadipocytes</strong> <strong>to</strong> <strong>adipose</strong> cells is the peroxisome proliferator-activated receptor &gamma; (<strong>PPAR&gamma;</strong>). It is a <strong>nuclear receptor</strong> that also binds the <strong>thiazolidinedione </strong>class of insulin-sensitizing drugs used in the treatment of type 2 diabetes mellitus.</p>\n<p>Note:&nbsp;<strong>Saroglitazar</strong>&nbsp;has a dual action on PPAR&alpha; and PPARùù≤ receptors.&nbsp;It reduces blood sugar and lipid levels in diabetic patients.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7031",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is incorrect regarding adiponectin?",
      "choices": [
        {
          "id": 1,
          "text": "Its levels are increased in obesity"
        },
        {
          "id": 2,
          "text": "It increases insulin sensitivity"
        },
        {
          "id": 3,
          "text": "Promotes lipid oxidation"
        },
        {
          "id": 4,
          "text": "Has vascular protective effects"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Adiponectin</strong> levels are <strong>reduced </strong>in<strong> obesity</strong>.</p>\n<p>It&nbsp;is an abundant adipose-derived protein with the following characteristics:&nbsp;</p>\n<ul>\n<li>Its levels are reduced in obesity</li>\n<li>It enhances <strong>insulin sensitivity</strong> and<strong> lipid oxidation</strong></li>\n<li>Has <strong>vascular-protective </strong>effects</li>\n</ul>\n<p>On the other hand, resistin and RBP4 levels, which are also secreted by adipocytes, may induce insulin resistance.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7034",
      "difficulty": "medium"
    },
    {
      "text": "A 2-year-old girl is referred to an endocrinologist with severe obesity and insatiable hunger despite adequate nutrition. Due to the early-onset severe obesity, genetic testing was done and revealed inactivating mutations in the leptin gene. Which of the following neuroendocrine abnormalities is this child most likely to develop?",
      "choices": [
        {
          "id": 1,
          "text": "Central hypothyroidism"
        },
        {
          "id": 2,
          "text": "Growth retardation"
        },
        {
          "id": 3,
          "text": "Hypogonadotropic hypogonadism"
        },
        {
          "id": 4,
          "text": "Diabetes mellitus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most prominent neuroendocrine abnormality seen in obese individuals with inactivating <strong>mutations</strong> in the <strong>leptin </strong>(ob gene) or&nbsp;leptin receptor (db gene) is <strong>hypogonadotropic hypogonadism.</strong></p>\n<p>Leptin mutations are responsible for a rare form of obesity that runs in families. These mutations&nbsp;<strong>prevent</strong> leptin from delivering <strong>satiety signals.&nbsp;</strong>Hence,&nbsp;the brain perceives starvation despite adequate nutrition. It results in morbid, <strong>early-onset</strong> <strong>obesity</strong>.</p>\n<p>Mutations in the following genes can cause <strong>obesity</strong> in humans:</p>\n<ul>\n<li>Lep (ob)</li>\n<li>LepR (db)</li>\n<li>POMC</li>\n<li>PC-1</li>\n<li>MC4R</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7035",
      "difficulty": "medium"
    },
    {
      "text": "Genetic mutations causing pro-opiomelanocortin (POMC) deficiency presents with all of the following except:",
      "choices": [
        {
          "id": 1,
          "text": "Œ±-MSH deficiency"
        },
        {
          "id": 2,
          "text": "Cachexia"
        },
        {
          "id": 3,
          "text": "Red hair pigmentation"
        },
        {
          "id": 4,
          "text": "Adrenal insufficiency"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Cachexia is not a feature of mutations of the pro-opiomelanocortin&nbsp;(<strong>POMC</strong>) gene. It is associated with the following characteristics:</p>\n<ul>\n<li>Absence of&nbsp;&alpha;-MSH\n<ul>\n<li>Severe <strong>obesity</strong>&nbsp;- &alpha;-MSH&nbsp;inhibits appetite in the hypothalamus</li>\n<li><strong>Pale skin</strong> and <strong>red hair&nbsp;</strong></li>\n</ul>\n</li>\n<li>Absence of ACTH\n<ul>\n<li>Secondary <strong>adrenal insufficiency&nbsp;</strong></li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7037",
      "difficulty": "medium"
    },
    {
      "text": "The production of which of the following hormones is increased in obesity?",
      "choices": [
        {
          "id": 1,
          "text": "Insulin"
        },
        {
          "id": 2,
          "text": "Thyroxine"
        },
        {
          "id": 3,
          "text": "Growth hormone"
        },
        {
          "id": 4,
          "text": "Adiponectin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Insulin levels are increased in <strong>obesity</strong>. It stimulates the <strong>synthesis of fatty acids</strong> and <strong>TAG</strong> and <strong>decreases</strong> the rate of <strong>lipolysis</strong>. <strong>Thyroxine</strong>, <strong>growth hormone</strong>, and <strong>adiponectin</strong> have <strong>lipolytic effects</strong>, hence their levels are <strong>reduced</strong> in obesity.</p>\n<p><strong>Hyperinsulinemia</strong> and <strong>insulin resistance</strong> are consistent features of obesity. Insulin resistance is more strongly linked to intra-abdominal fat than to fat in other areas. </p>\n<p><strong>Adiponectin</strong> (Option D) is an <strong>anti-inflammatory cytokine</strong> that is produced by adipocytes. It performs vital functions that are reduced in obesity - like, <strong>increasing insulin sensitivity</strong> and the <strong>inhibition of gluconeogenic enzymes</strong>. It also enhances <strong>fatty acid oxidation</strong>. </p>\n<p><strong>Insulin resistance</strong> in obesity occurs as a result of the following:</p>\n<ul>\n<li>Insulin <strong>receptor downregulation</strong></li>\n<li><strong>Increased FFA</strong> (free fatty acids) and capable of impairing insulin action</li>\n<li>Intracellular lipid accumulation</li>\n<li><strong>Circulating peptides</strong> produced by adipocytes such as <strong>TNF-&alpha;</strong>, <strong>IL-6</strong>,<strong> RBP4</strong>, and <strong>resistin</strong> modify insulin action.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7038",
      "difficulty": "medium"
    },
    {
      "text": "In a child with obesity, hypogonadism, and mental retardation, which of the following would you not suspect ?",
      "choices": [
        {
          "id": 1,
          "text": "Prader-Willi syndrome"
        },
        {
          "id": 2,
          "text": "Laurence-Moon-Bardet-Biedl syndrome"
        },
        {
          "id": 3,
          "text": "Carpenter syndrome"
        },
        {
          "id": 4,
          "text": "Angelman syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Children with <strong>Angelman </strong>syndrome present with <strong>mental retardation</strong> but do not have obesity and hypogonadism. It occurs due to the deletion of band q12 of the <strong>maternal</strong> <strong>chromosome</strong> <strong>15</strong>.</p>\n<p>The following syndromes present with obesity, hypogonadism, and mental retardation</p>\n<ul>\n<li>Prader-Willi syndrome -&nbsp;deletion of band q12 of the <strong>paternal</strong> chromosome <strong>15</strong>.</li>\n<li>Laurence-Moon-Bardet-Biedl syndrome</li>\n<li>Carpenter syndrome</li>\n<li>Cohen syndrome</li>\n</ul>\n<p>The following image shows a child with Prader-Willi syndrome.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f5c80982639e4725b4d238f53026d6afx572x903.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7039",
      "difficulty": "hard"
    },
    {
      "text": "Obesity is not seen in patients with which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Craniopharyngioma"
        },
        {
          "id": 2,
          "text": "Pickwickian syndrome"
        },
        {
          "id": 3,
          "text": "Prader-Willi syndrome"
        },
        {
          "id": 4,
          "text": "Sipple syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Sipple </strong>syndrome is characterized&nbsp;by&nbsp;<strong>pheochromocytoma</strong> which is associated with <strong>weight loss</strong>.</p>\n<p>Obesity is seen in the following syndromes:</p>\n<ul>\n<li>Cushing's syndrome</li>\n<li><strong>Prader-Willi</strong> syndrome</li>\n<li><strong>Pickwickian</strong> syndrome</li>\n<li>Hypothyroidism</li>\n<li>Insulinoma</li>\n<li><strong>Craniopharyngioma</strong> and other hypothalamic disorders</li>\n<li>Laurence-Moon-Bardet-Biedl syndrome</li>\n<li>Carpenter syndrome</li>\n<li>Cohen syndrome</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7040",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old woman is being evaluated for high blood glucose levels. On examination, acanthosis nigricans is noted, and her BMI is 34 kg/m¬≤. How would you classify her weight?",
      "choices": [
        {
          "id": 1,
          "text": "Overweight"
        },
        {
          "id": 2,
          "text": "Class I obesity"
        },
        {
          "id": 3,
          "text": "Class II obesity"
        },
        {
          "id": 4,
          "text": "Class III obesity"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>According to the WHO classification, a BMI of 34¬†kg/m¬≤ would be classified as<strong> class I</strong> obesity.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>¬†¬†¬†¬†¬†¬† <strong>Classification</strong></p>\n</td>\n<td>\n<p><strong>BMI (kg/m¬≤)</strong></p>\n</td>\n<td>\n<p>¬† ¬† ¬† ¬†¬†<strong>Risk</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Underweight</p>\n</td>\n<td>\n<p>¬†¬†¬† &lt;18.5</p>\n</td>\n<td>\n<p>¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬† -</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Normal weight</p>\n</td>\n<td>\n<p>¬† 18.5‚Äì24.9</p>\n</td>\n<td>\n<p>¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬† -</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>¬†Overweight</p>\n</td>\n<td>\n<p>¬†¬†¬† 25‚Äì29.9</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>¬†Obesity (Class I)</p>\n</td>\n<td>\n<p>¬†¬† 30‚Äì34.9</p>\n</td>\n<td>\n<p>High</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Obesity (Class II)</p>\n</td>\n<td>\n<p>¬†¬† 35‚Äì39.9</p>\n</td>\n<td>\n<p>Very high</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Extreme obesity(Class III)</p>\n</td>\n<td>\n<p>¬†¬†¬†¬† ‚â• 40</p>\n</td>\n<td>\n<p>Extremely high</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The revised BMI classification for Asians/Indians is as follows:</p>\n<ul>\n<li>Underweight - BMI &lt; 18.5 kg/m<sup>2</sup>¬†</li>\n<li>Normal or lean - BMI 18.5‚Äì22.9 kg/m<sup>2</sup>¬†</li>\n<li>Overweight - BMI 23.0 ‚Äì24.9 kg/m<sup>2</sup>¬†</li>\n<li>Obese BMI ‚â•25 kg/m<sup>2</sup></li>\n</ul>\n<p>Note: As the question does not specify Asian/Indian, the answer is given according to WHO classification.</p><p class=\"p1\">A recent study shows that people with a body mass index(BMI) more than or equal to 35 is associated with a higher risk of death in patients with COVID-19.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7041",
      "difficulty": "medium"
    },
    {
      "text": "A known patient of type 2 diabetes mellitus on oral medication presents to your OPD for review. His blood pressure is 150/90 mm Hg and his BMI is 28.4 kg/m¬≤. His fasting glucose is 118 mg/dl and postprandial glucose is 154 mg/dl. He consumes a low-calorie diet and exercises regularly. How will you manage his obesity?",
      "choices": [
        {
          "id": 1,
          "text": "Start him on a more intense diet and exercise regimen"
        },
        {
          "id": 2,
          "text": "Anti-obesity drugs in combination with proper diet and exercise"
        },
        {
          "id": 3,
          "text": "Refer for bariatric surgery"
        },
        {
          "id": 4,
          "text": "Anti-obesity drugs alone as lifestyle changes have not been effective"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This obese man with a BMI of 28.4&nbsp;kg/m&sup2; along with comorbidities must be managed with <strong>anti-obesity drugs</strong> as an adjunct to comprehensive lifestyle modifications.</p>\n<p>The recommendations for management of obesity are as follows:</p>\n<ul>\n<li>Diet, exercise, behavioral therapy:&nbsp;<br />\n<ul>\n<li>BMI - 25-29.9 with comorbidities</li>\n<li>BMI &ge; 30</li>\n</ul>\n</li>\n<li><strong>Adjunctive</strong> <strong>pharmacotherapy:</strong>\n<ul>\n<li>BMI - 27-29.9 with comorbidities</li>\n<li>BMI &ge; 30</li>\n</ul>\n</li>\n<li><strong>Bariatric surgery:</strong>\n<ul>\n<li>BMI - 35-39.9 with comorbidities</li>\n<li>BMI &ge;&nbsp;40</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7042",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following anti-obesity drugs is a selective 5-HT2C receptor agonist?",
      "choices": [
        {
          "id": 1,
          "text": "Orlistat"
        },
        {
          "id": 2,
          "text": "Phentermine"
        },
        {
          "id": 3,
          "text": "Lorcaserin"
        },
        {
          "id": 4,
          "text": "Topiramate"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Lorcaserin</strong> is a selective <strong>5-HT2C receptor</strong>&nbsp;agonist with a functional selectivity ~15 times that of 5-HT2A receptors and 100 times that of 5-HT2B&nbsp; receptors.</p><p class=\"p1\">Based on a safety clinical trial, the FDA has announced, withdrawal of the drug lorcarserin on Feb 13th 2020, as the potential risk of <strong>cancer</strong> outweighs the benefits.</p><hr><h3>Related Pearl: Anti-obesity drugs</h3><p><strong>Centrally acting </strong>anti-obesity drugs: The biologic effect of these agents on appetite regulation is produced by <strong>augmentation</strong> of the neurotransmission of three monoamines,¬†<strong>norepinephrine</strong>, <strong>serotonin</strong> (<strong>5-HT</strong>) and¬†<strong>dopamine</strong>.</p>\n<ul>\n<li><strong>Phentermine </strong>‚Äì Sympathomimetic (Phentermine is usually used in combination with <strong>topiramate</strong>)</li>\n<li><strong>Lorcaserin</strong> ‚Äì Selective 5-HT2C receptor agonist</li>\n</ul>\n<p><strong>Peripherally acting </strong>medications:</p>\n<ul>\n<li><strong>Orlistat</strong> is a synthetic hydrogenated derivative of a naturally occurring <strong>lipase inhibitor,</strong> lipostatin, that is produced by the mold <em>Streptomyces toxytricini</em>.</li>\n</ul>\n<p>Anti-obesity drugs in development:</p>\n<ul>\n<li><strong>Bupropion</strong>:<strong>¬†</strong>Dopamine and norepinephrine reuptake inhibitor</li>\n<li><strong>Naltrexone</strong>:<strong>¬†</strong>Opioid receptor antagonist</li>\n</ul>\n<p><strong>Liraglutide</strong>:<strong>¬†</strong>Glucagon-like peptide 1 receptor agonist</p>\n<p>Note: Tirzepatide is a GIP and GLP-1 agonist recently approved for weight loss treatment.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7043",
      "difficulty": "medium"
    }
  ]
}